(Q47998164)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23859570%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

meta-analysis

0 references

title

SCN1A, SCN2A and SCN3A gene polymorphisms and responsiveness to antiepileptic drugs: a multicenter cohort study and meta-analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23859570%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23859570%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Patrick Kwan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23859570%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Zahurin Mohamed

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23859570%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

author name string

Batoul Sadat Haerian

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23859570%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Hui Jun Tan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23859570%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Azman Ali Raymond

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23859570%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

publication date

1 July 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23859570%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23859570%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23859570%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23859570%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

page(s)

1153-1166

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23859570%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

cites work

Drug-resistant epilepsy

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.104

New developments in antiepileptic drug resistance: an integrative view

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.104

The crystal structure of a voltage-gated sodium channel

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.104

Voltage-gated sodium channels at 60: structure, function and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.104

Neurological perspectives on voltage-gated sodium channels.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.104

Gene variants affect response to antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.104

Voltage-gated sodium channels as therapeutic targets in epilepsy and other neurological disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.104

Sodium channel blockers as therapeutic target for treating epilepsy: recent updates

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.104

Genetic predictors of the maximum doses patients receive during clinical use of the anti-epileptic drugs carbamazepine and phenytoin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.104

Nova2 interacts with a cis-acting polymorphism to influence the proportions of drug-responsive splice variants of SCN1A.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.104

A functional polymorphism in the SCN1A gene is not associated with carbamazepine dosages in Austrian patients with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.104

Association of polymorphisms in EPHX1, UGT2B7, ABCB1, ABCC2, SCN1A and SCN2A genes with carbamazepine therapy optimization.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.104

Association between SCN1A polymorphism and carbamazepine-resistant epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.104

Multidrug resistance in epilepsy and polymorphisms in the voltage-gated sodium channel genes SCN1A, SCN2A, and SCN3A: correlation among phenotype, genotype, and mRNA expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.104

Gene-to-gene interaction between sodium channel-related genes in determining the risk of antiepileptic drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.104

Differential role of sodium channels SCN1A and SCN2A gene polymorphisms with epilepsy and multiple drug resistance in the north Indian population

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.104

Genetic factors associated with drug-resistance of epilepsy: relevance of stratification by patient age and aetiology of epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.104

Pharmacogenomic association study on the role of drug metabolizing, drug transporters and drug target gene polymorphisms in drug-resistant epilepsy in a north Indian population

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.104

A functional polymorphism in the SCN1A gene does not influence antiepileptic drug responsiveness in Italian patients with focal epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.104

SCN1AIVS5-91G>A polymorphism is associated with susceptibility to epilepsy but not with drug responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.104

SCN1A IVS5N+5 polymorphism and response to sodium valproate: a multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.104

Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.104

The new ILAE report on terminology and concepts for organization of epileptic seizures: a clinician's critical view and contribution

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.104

Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.104

A simplified universal genomic DNA extraction protocol suitable for PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.104

A minimally invasive method of piscine tissue collection and an analysis of long-term field-storage conditions for samples.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.104

Biased tests of association: comparisons of allele frequencies when departing from Hardy-Weinberg proportions

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.104

Development and validation of MIX: comprehensive free software for meta-analysis of causal research data

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.104

Power and sample size calculations for studies involving linear regression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.104

Designing genome-wide association studies: sample size, power, imputation, and the choice of genotyping chip

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.104

Early identification of refractory epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.104

The mechanisms of action of valproate in neuropsychiatric disorders: can we see the forest for the trees?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.104

Carbamazepine versus valproate monotherapy for epilepsy: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.104

Drug resistance in epilepsy: putative neurobiologic and clinical mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.104

Comprehensive analysis of the association of SCN1A gene polymorphisms with the retention rate of carbamazepine following monotherapy for new-onset focal seizures in the Chinese Han population

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.104

Effects of SCN1A and GABA Receptor Genetic Polymorphisms on Carbamazepine Tolerability and Efficacy in Chinese Patients with Partial Seizures: 2-Year Longitudinal Clinical Follow-Up

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.104

Two-stage genome-wide association study identifies variants in CAMSAP1L1 as susceptibility loci for epilepsy in Chinese

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.104

A common polymorphism in the SCN1A gene associates with phenytoin serum levels at maintenance dose

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.104

Quality control in molecular genetic testing

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.104